All of the big thinkers who ponder the problem of shrinking working class income miss the most obvious solution of all: unions with real power. The Republicans have somehow convinced the working class that unions are the enemy and that there's something decadent about a manual worker making a living wage. Everyone bought the idea that the coddled American industrial worker had to be thrown into the ring with workers from third world countries. The days are gone when the Democratic party would not dare to displease the CIO. If nothing else, the Trump and Sanders campaigns call into question the orthodoxy that anything which brings down the cost of manufactures is essentially good. It's ironic that a oligarch and an old Trotskyite are voicing the complaints which should rightly be advanced by the union movement.
Yes, they cannily rejected that $12 offer from Shire and that $15 offer from Allergan and chose instead to sell 30m shares to some mysterious party @ $3. The source for this information is that same one you have cited repeatedly: Source.
Hawk has posted today that "the hopeometer level has definitely been raised". Now I understand how I have been consistently underrating this great company. I just checked my hopeometer and found that the batteries are dead!
Can't believe that you are questioning that unimpeachable source, "Source".
Actually, I sold out of all my IRWD at just under 10, which turned out to be too soon. I wasn't excited about their purchase of the rights to the gout drug (It pushed their profitability further out,) and the Phase Four (?) attack was the final straw. Even it was untrue, it injected too much risk into the stock. And yes, I did make a small profit on the sale since my average price was around 8.50. But my rule is to buy a stock under a fixed premise - in this case, the premise was that the company would be cash flow positive very soon. When something happens which calls my premise into question, I dump it.
Yes, I've been away on vacation. Did the Big Buyout happen yet? Was it for 15, as most here had surmised? Or did Shire lowball you at 12?
Back in just under 88, calculating that you are not only getting GILD cheap - you are also getting the company that they will eventually buy with all that cash for free.
Ps The plan that IRWD has followed in partnering with international drug companies in the development of Linzess is a virtual carbon copy of the plan that Medivation used in partnering with Astellas in developing Xtandi. That's worked out pretty well, I'd say,.
You say they sold the international rights for "a small royalty". They sold half the international rights - and the US rights - for substantial upfront payments and milestone payments. They get half the European and Mexican profits while their partners cover all of the developmental and marketing costs. In the case of the Chinese, Japanese, and other Asian markets, they get 50% of the profits, which eventually escalate to 55%. To this point, their partners have invested about $850 million in the development of Linzess.
Synergy is almost broke. They have about $80 million left and are burning through more than $25 million a quarter. They don't even have the cash to get to the end of the year, much less launch plecanatide, which will cost them at least an additional $200 milion in the initial year alone. Yeah, good luck, longs.
These Harvard guys are touchy. Maybe the Linzess rep parked in his space.
Well, we can debate the arcana of trials and statistics, but one wonders: Even before FDA approval, Ironwood had signed partnerships worldwide. If the plecanatide trials are so impressive, why have they never signed a partnership with anyone? Why, as I have asked before, has no one ever taken a nibble out of that luscious plecanatide pie?
I think that this quack and gia are just upset because Linda, the Lovely Linzess Lady, spurned their advances.
If you post verifiable facts and numbers here, they will be assailed as lies. If you post fantasies about $15 buyouts, you willbe commended for your financial acumen.
Just posting this again, rather than reconstruct the whole thing. A CIC drug which does not, at some dosage, produce diarrhea is like a nonflammable lighter fluid: very, very safe.
When will Allergan buy Synergy? When Donald Trump sees Ted Cruz drowning in the pool at Mar a Lago and jumps in to save him.
Bought more today at 10.39-10.40. Sold them at 10.75. If the market had held up, it would have gone to 11. Ironwood will be cash flow positive before plecanatide is approved.
When a stock pops at the open, then trades huge volume but is unable to advance beyond the initial pop, good sense would tell you that it is being sold into the heavy volume smokescreen. (i.e. The short position is back.)